![This fall's COVID vaccines aren't always easy to get or get insurance to cover : Shots - Health News : NPR This fall's COVID vaccines aren't always easy to get or get insurance to cover : Shots - Health News : NPR](https://media.npr.org/assets/img/2023/09/27/ap23023643681288-1--efc059a38509909d4dc973b421c367630741d549.jpg)
This fall's COVID vaccines aren't always easy to get or get insurance to cover : Shots - Health News : NPR
![With COVID hospitalizations rising, Duke experts urge people who are eligible to get the next COVID booster | NC Newsline With COVID hospitalizations rising, Duke experts urge people who are eligible to get the next COVID booster | NC Newsline](https://ncnewsline.com/wp-content/uploads/2023/08/Vaccine-nurse-Getty-1024x683.jpeg)
With COVID hospitalizations rising, Duke experts urge people who are eligible to get the next COVID booster | NC Newsline
![FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN](https://media.cnn.com/api/v1/images/stellar/prod/230109124641-moderna-bivalent-vaccine.jpg?c=original)
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
![Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ... Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...](https://www.cdc.gov/mmwr/volumes/72/wr/social-media/mm7205e1_BivalentVECurrentSublineages_IMAGE_25Jan2023_1200x675-medium.jpg?_=95835)
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
![Covid vaccine for fall 2023: The rollout could begin as early as mid-September | Pittsburgh Post-Gazette Covid vaccine for fall 2023: The rollout could begin as early as mid-September | Pittsburgh Post-Gazette](https://9b16f79ca967fd0708d1-2713572fef44aa49ec323e813b06d2d9.ssl.cf2.rackcdn.com/1140x_a10-7_cTC/FILES-US-HEALTH-VIRUS-VACCINE-14-1-1694037535.jpg)
Covid vaccine for fall 2023: The rollout could begin as early as mid-September | Pittsburgh Post-Gazette
![CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News](https://i.abcnewsfe.com/a/8751bb25-b566-4440-9e9c-72099e9696bf/covid-2-rt-bb-230906_1694012668027_hpEmbed_3x2.jpg)
CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News
![Looking Ahead at COVID, Flu, and RSV Vaccines for Fall 2023 | Johns Hopkins | Bloomberg School of Public Health Looking Ahead at COVID, Flu, and RSV Vaccines for Fall 2023 | Johns Hopkins | Bloomberg School of Public Health](https://publichealth.jhu.edu/sites/default/files/styles/article_feature/public/2023-07/rsv-covid-flu-vaccines.png?h=6e972868&itok=ZF7GqaxJ)
Looking Ahead at COVID, Flu, and RSV Vaccines for Fall 2023 | Johns Hopkins | Bloomberg School of Public Health
![COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/372ade5e-5f14-48a9-b960-4b5767839337/gr1_lrg.jpg)